DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Ginès P, Wong F, Watson H.
Long-term improvement of serum sodium by the V2-receptor antagonist satavaptan in patients with cirrhosis and hyponatremia
J Hepatol 2007; 46: 90A-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.